SWS Hemodialysis Care Co., Ltd. Class A

As of June 30, 2026, SWS Hemodialysis Care Co., Ltd. Class A carries a market capitalization of 4.59B, placing it among publicly traded companies globally. Its enterprise value stands at 3.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

SWS Hemodialysis Care Co., Ltd. Class A's next confirmed earnings release is scheduled for October 28, 2026.

As of June 30, 2026, SWS Hemodialysis Care Co., Ltd. Class A has 447.44M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, SWS Hemodialysis Care Co., Ltd. Class A maintains a current ratio of 3.35, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, SWS Hemodialysis Care Co., Ltd. Class A recorded 19.17M in income tax expense.

As of the close on October 22, 2026, SWS Hemodialysis Care Co., Ltd. Class A's stock has declined approximately 8.40% over the past 52 weeks. The 50-day moving average sits at 10.06, while the 200-day moving average is 10.95.

As of June 30, 2026, SWS Hemodialysis Care Co., Ltd. Class A holds 1.41B in cash and equivalents against 2.21M in total debt, resulting in a net debt position of -734.86M. Total book value stands at 1.81B, with working capital of 1.24B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

SWS Hemodialysis Care Co., Ltd. Class A's most recent stock split took place on July 10, 2026 with a 5:7 split ratio.